RIL
FATE icon

Rothschild Investment LLC’s Fate Therapeutics FATE Stock Holding History

Rothschild Investment LLC’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38K Buy
1,622
+937
+137% +$1.73K ﹤0.01% 2360
2026
Q1 		$822 Buy
685
+658
+2,437% +$801 ﹤0.01% 2952
2025
Q4 		$27 Buy
+27
New +$32 ﹤0.01% 3317
2025
Q2 		– Sell
-70
Closed -$55 – 3077
2025
Q1 		$55 Hold
70
– – ﹤0.01% 2997
2024
Q4 		$116 Buy
70
+30
+75% +$76 ﹤0.01% 2889
2024
Q3 		$140 Buy
40
+5
+14% +$19 ﹤0.01% 2781
2024
Q2 		$115 Buy
+35
New +$153 ﹤0.01% 2695
2023
Q1 		– Sell
-15,600
Closed -$157K – 490
2022
Q4 		$157K Sell
15,600
-1,650
-10% -$31K 0.01% 448
2022
Q3 		$387K Buy
+17,250
New +$498K 0.04% 314

Other funds holding FATE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Rothschild Investment LLC's FATE Position: Q2 2026 in Review

Rothschild Investment LLC increased its Fate Therapeutics (FATE) stake by 137% in Q2 2026, buying an estimated $1.73K and bringing the position to 1,622 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Rothschild Investment LLC first reported a position in FATE in Q3 2022 and has held it in 9 quarters since. The position peaked at $387K in Q3 2022. 53 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Rothschild Investment LLC held 1,622 shares of Fate Therapeutics worth $4.38K as of Q2 2026.
  • Rothschild Investment LLC bought 937 Fate Therapeutics shares in Q2 2026, an estimated $1.73K.
  • Fate Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2360 holding.
  • Rothschild Investment LLC first reported a position in Fate Therapeutics in Q3 2022 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Fate Therapeutics position peaked at $387K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.